← Eichor
Condition: Add Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Add

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Pa
Phase 3 · 60 location(s) · ECOG-ACRIN Cancer Research Group · NCT05863195Metacognitive Intervention in Children and Adolescents With ADHD - MiA Study
NA · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT07162831Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an An
Phase 3 · 82 location(s) · Children's Oncology Group · NCT06647953Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carbo
Phase 2 · 34 location(s) · National Cancer Institute (NCI) · NCT05198830Marshall Vein Ethanol Infusion in Addition to Pulsed Electric Field Ablation Versus Pulsed Electric Field Ablation Alone
NA · 1 location(s) · Beijing Anzhen Hospital · NCT07095959Effects of Band Exercises Added to the Warm-Up on Shooting and Viscoelastic Properties of Muscles in Handball Players
NA · 1 location(s) · Marmara University · NCT06685666A Clinical Trial Evaluating the Safety and Efficacy of AP1189 Versus Placebo as an add-on to Standard of Care in Partici
Phase 2 · 11 location(s) · SynAct Pharma Aps · NCT07633288Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patient
Phase 2 · 153 location(s) · NRG Oncology · NCT06532279Omega-3 Fatty Acids, Neuroendocrine and Attention Deficit Hyperactivity Disorder (OMNeADHD)
NA · 1 location(s) · China Medical University Hospital · NCT07364331Motor Attention Training for Attention Deficit Hyperactivity Disorder (ADHD)
NA · 1 location(s) · University of Wisconsin, Madison · NCT02688959Scalene Hold Relax Technique With Conventional Physical Therapy in Asthma
NA · 1 location(s) · Riphah International University · NCT07103512Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer
Phase 1 · 27 location(s) · National Cancer Institute (NCI) · NCT04633239Progel Platinum for Air Leak Reduction After VATS Lobectomy for NSCLC
NA · 6 location(s) · Fondazione del Piemonte per l'Oncologia · NCT07479277Optimizing Research With Diverse Families - Feasibility and Acceptability Study (FAST)
NA · 1 location(s) · Oregon Health and Science University · NCT06133231The Added-value of PSMA PET in Detecting Clinically Significant Prostate Cancer Lesions in Patients Undergoing MRI-targe
NA · 1 location(s) · Jules Bordet Institute · NCT06867588Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastati
Phase 1 · 22 location(s) · National Cancer Institute (NCI) · NCT05803382Effect of Additional Sural Nerve PRF in Chronic Heel Pain
Phase N/A · 1 location(s) · Diskapi Teaching and Research Hospital · NCT07383558Feasibility and Efficacy of Attentional-Control Training in Sickle Cell Disease
NA · 1 location(s) · Children's National Research Institute · NCT05099874Improving ADHD Teen Driving - Virtual Reality
NA · 1 location(s) · Children's Hospital Medical Center, Cincinnati · NCT06960980Implementation of a Home-based Computerized Cognitive Rehabilitation Program for Patients With ABI
NA · 1 location(s) · Erasmus Medical Center · NCT06749197Rocklatan vs Latanoprost Post-DSLT
Phase 4 · 1 location(s) · Eye Centers of Southeast Texas · NCT07465913Added Value of Reconstructive Lymphatic Surgery to Usual Care in Lymphoedema
NA · 3 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT05064176A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · 202 location(s) · National Cancer Institute (NCI) · NCT05691478SGLT2 Inhibition in Addition to Lifestyle Intervention and Risk for Complications in Subtypes of Patients With Prediabet
Phase 4 · 9 location(s) · University Hospital Tuebingen · NCT06054035REperfusion With P2Y12 Inhibitors in Addition to mEchanical thRombectomy for perFUsion Imaging Selected Acute Stroke pat
Phase 3 · 13 location(s) · Fondation Ophtalmologique Adolphe de Rothschild · NCT04667078A Parent-child Yoga Intervention for Reducing Attention Deficits in Children with Congenital Heart Disease: a Feasibilit
NA · 2 location(s) · Anne Gallagher · NCT05997680Metastases Directed Therapy for Oligometastatic Breast Cancer
NA · 1 location(s) · National Cancer Institute, Egypt · NCT06144346Addition of Hypofractionated High Dose Radiation in Oligometastatic Disease
Phase 3 · 6 location(s) · Vastra Gotaland Region · NCT06141070Venetoclax-Obinutuzumab +/- Acalabrutinib in R/R CLL
Phase 2 · 3 location(s) · Massachusetts General Hospital · NCT04560322Study of COYA 302 for the Treatment of ALS
Phase 2 · 25 location(s) · Coya Therapeutics · NCT07161999
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.